“…11 Amantadine is a substance used in the treatment of Parkinson's disease and Parkinson's syndromes, as well as a drug against influenza A virus. 16,17 In the CSD there are some crystal structures of amantadine salts with bioactive components such as: indomethacin in conjunction with L-amino acids, 18 sulfamethoxazole, 19 [1-(dibenzylamino)ethyl] phosphonic acid, 20 fumaric acid, 21 oxalic acid, 4-aminobenzoic acid, glutaric acid, saccharin, 22 gemfibrozil, 23 sulfathiazole, 24 resveratrol, 25 and 3,7,12trihydroxycholan-24-oic acid 26 as well as salts with NSAIDs: indomethacin, diclofenac, and mefenamic, meclofenamic, flufenamic, tolfenamic acids. 27 In this paper we present two polymorphic structures of a new salt of niflumic acid with amantadine, which may be a potential new form of medicine exhibiting a synergistic therapeutic effect due to a change in properties.…”